Feasibility and clinical outcomes of 48 mm drug eluting stents in management of patients with coronary artery disease

Back

ESC Professional Premium Access

Feasibility and clinical outcomes of 48 mm drug eluting stents in management of patients with coronary artery disease

Session: Coronary artery disease - Revascularisation 4

Topic: Revascularisation

Speaker: Doctor A. El Amrawy (Alexandria, EG)

Event: ESC Congress 2022

Congress Presentation

Add to my library

About the speaker

Doctor Ahmed El Amrawy

Faculty of Medicine Alexandria University, Alexandria (Egypt)

0 follower

5 more presentations in this session

The long-term cardiac events after coronary bifurcation stenting with second-generation drug-eluting stents in elderly patients are comparable to those of younger patients

Speaker: Professor J. Park (Seoul, KR)

Access

Abstract

Slides

In-hospital and long-term outcomes of percutaneous coronary interventions for chronic total occlusions in patients with contrast-associated acute kidney injury

Speaker: Doctor P. Tajti (Bonyhad, HU)

Access

Abstract

Slides

ST Segment myocardial infarction due to totally occluded unprotected left main coronary artery (TOULM): an insight from nationwide database

Speaker: Doctor A. Arabi (Doha, QA) Doctor I. Rafie (Doha, QA)

Access

Abstract

Slides

PCI of chronic total occlusions: what is the clinical benefit and impact on quality of life?

Speaker: Doctor H. Costa (Faro, PT)

Access

Abstract

Slides

Clinical outcomes of percutaneous coronary intervention and rotational atherectomy using second generation drug eluting stents: a Korean multicentre analysis

Speaker: Doctor K. Kim (Seoul, KR)

Access

Abstract

Slides

Access the full session

Coronary artery disease - Revascularisation 4

Speakers: Doctor A. El Amrawy, Professor J. Park, Doctor P. Tajti, Doctor A. Arabi, Doctor I. Rafie...

Access

About the event

ESC Congress 2022

26 August - 29 August 2022

Sessions Presentations

Congress

ESC 365 is supported by

Explore sponsored resources